Clinical Trials

Colorectal Neoplasms

NCT06807437 2026-03-31

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

274 enrolled

Pancreatic Neoplasms

NCT07018869 2026-03-31

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

1,057 enrolled

Phase 2 Active not recruiting

Colorectal Neoplasms

NCT02437851 2026-03-30

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

16 enrolled

Anal Canal Carcinoma, Anus Neoplasms, HIV Infections

NCT06998940 2026-03-27

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

94 enrolled

GastrointestinalGynecologicLymphoidSarcoma

Pancreatic Neoplasms

NCT05510908 2026-03-25

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Completed

460 enrolled 7 charts

AIDS-related Kaposi sarcoma, Acquired Immunodeficiency Syndrome, Anus Neoplasms, Uterine Cervical Neoplasms, Lymphoma, Neoplasms, Sarcoma, Kaposi, HIV Infections, Lymphoma, AIDS-Related

NCT04166318 2026-03-23

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Phase 2 Active not recruiting

252 enrolled

Phase 2 Active not recruiting

Anal Canal Carcinoma, Anus Neoplasms

NCT04233866 2026-03-23

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

176 enrolled

Phase NA Active not recruiting

Pancreatic Neoplasms

NCT04239573 2026-03-23

Comparing Two Methods to Follow Patients With Pancreatic Cysts

4,606 enrolled

Phase 3 Active not recruiting

Pancreatic Neoplasms

NCT04248452 2026-03-23

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

314 enrolled

Adenocarcinoma Of Esophagus

NCT05863195 2026-03-23

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

408 enrolled

Phase 2/3 Active not recruiting

Colorectal Neoplasms

NCT04559139 2026-03-19

Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

186 enrolled

Gallbladder Neoplasms

NCT03516942 2026-03-13

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

Active not recruiting

565 enrolled 16 charts

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Colonic Neoplasms, Rectal Neoplasms

NCT04851119 2026-02-24

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Phase 1/2 Recruiting

147 enrolled

Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Melanoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Ewing, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Hepatoblastoma, Desmoid Tumors

NCT06620302 2026-02-24

Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma

Phase 1/2 Recruiting

81 enrolled

Fibrolamellar hepatocellular carcinoma

NCT03365882 2026-02-10

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

240 enrolled 14 charts

Colonic Neoplasms, Rectal Neoplasms

NCT01730937 2026-01-28

Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Phase 3 Completed

193 enrolled 29 charts

Carcinoma, Hepatocellular

NCT06976710 2026-01-22

PC2

Phase NA Recruiting

564 enrolled

Colorectal Neoplasms

NCT03768414 2026-01-12

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

Phase 3 Completed

452 enrolled 17 charts

Phase 3 Active not recruiting

Gallbladder Neoplasms, Cholangiocarcinoma

NCT03533582 2025-12-22

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

537 enrolled

Fibrolamellar hepatocellular carcinoma, Hepatoblastoma

NCT07098871 2025-12-16

Predictive Value of Preoperative Rectus and Diaphragm Muscle Thickness for Postoperative Complications in Gastrointestinal Cancer Surgery

Recruiting

300 enrolled

Gastrointestinal Neoplasms, Postoperative Complications

NCT05694936 2025-09-18

Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

90 enrolled

Phase NA Active not recruiting

Colorectal Neoplasms

NCT00819208 2025-09-16

CHALLENGE

889 enrolled

Phase NA Active not recruiting

Anxiety Disorders, Colonic Neoplasms, Depression, Fatigue, Sleep Wake Disorders, Colorectal Neoplasms

NCT03822572 2025-09-10

ABCSG C08

92 enrolled

Colorectal Neoplasms

NCT02598349 2025-09-09

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

60 enrolled

Pancreatic Neoplasms

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

GastrointestinalOtherPlasma cell

43 enrolled 23 charts

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

NCT07104175 2025-08-05

Predictive Value of NRS2002 and GLIM for Complications After GI Malignancy Surgery

Completed

471 enrolled

BreastGastrointestinalGenitourinary

Gastrointestinal Malignancies

NCT06462963 2025-08-01

SPRINT

Phase NA Recruiting

302 enrolled

Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT02205047 2025-07-31

INNOVATION

172 enrolled

Stomach Neoplasms

NCT06441747 2025-07-29

Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

40 enrolled

Cholangiocarcinoma

NCT06290505 2025-07-23

PALEO

54 enrolled

GastrointestinalLymphoidOther hematologic neoplasmSarcoma

Esophageal Neoplasms

NCT05663502 2025-07-17

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Recruiting

200 enrolled

Multi-centric Castleman's Disease, Plasmablastic Lymphoma, Anus Neoplasms, Lymphoma, Sarcoma, Kaposi, HIV Infections, Hematologic Neoplasms

NCT07058012 2025-07-10

EMPIRE

Phase 2 Not yet recruiting

79 enrolled

Colonic Neoplasms

NCT01726309 2025-07-08

Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4

Terminated

161 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT02050737 2025-07-08

Plasma Biomarkers C-RAC, ICORG 12-27, V1

Terminated

109 enrolled

Colorectal Neoplasms

NCT03153280 2025-07-08

Lithium

Phase 1 Terminated

2 enrolled

Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT06149546 2025-07-08

FEED

Phase NA Recruiting

70 enrolled

Phase 1 Not yet recruiting

Pancreatic Neoplasms

NCT06978062 2025-06-05

NeoBEMA

27 enrolled

GastroEsophageal Cancer

NCT00324415 2025-05-30

Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer

45 enrolled 17 charts

Anal Canal Carcinoma, Anus Neoplasms

NCT05551052 2025-05-29

CRC-DRAW

Active not recruiting

196 enrolled